XTL Biopharmaceuticals Ltd ADR (XTLB) — Financial Flexibility Index
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Financial Flexibility Index of -10.73x as of December 2022. Free cash flow of $-2.01 Million (operating CF $-2.01 Million minus capex $0.00) represents -11% of total liabilities ($187.00K). Also explore net asset momentum of XTL Biopharmaceuticals Ltd ADR to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
XTL Biopharmaceuticals Ltd ADR Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for XTL Biopharmaceuticals Ltd ADR across 22 annual periods. Check XTL Biopharmaceuticals Ltd ADR strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for XTL Biopharmaceuticals Ltd ADR (2003–2024)
Year-by-year free cash flow to debt coverage for XTL Biopharmaceuticals Ltd ADR. For the full company profile including market capitalisation, see XTL Biopharmaceuticals Ltd ADR stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.50x | $-1.56 Million | $-1.62 Million | $3.12 Million | ▲ +85.4% |
| 2023 | -3.43x | $-707.00K | $-707.00K | $206.00K | ▲ +28.8% |
| 2022 | -4.82x | $-901.00K | $-901.00K | $187.00K | ▼ -490.2% |
| 2021 | -0.82x | $-1.05 Million | $-1.05 Million | $1.28 Million | ▲ +75.6% |
| 2020 | -3.34x | $-849.00K | $-850.00K | $254.00K | ▲ +14.4% |
| 2019 | -3.91x | $-906.00K | $-908.00K | $232.00K | ▼ -21.4% |
| 2018 | -3.22x | $-814.00K | $-816.00K | $253.00K | ▼ -750.0% |
| 2017 | -0.38x | $-1.12 Million | $-1.12 Million | $2.97 Million | ▲ +92.5% |
| 2016 | -5.05x | $-1.67 Million | $-1.73 Million | $330.00K | ▼ -22.6% |
| 2015 | -4.12x | $-1.79 Million | $-1.86 Million | $436.00K | ▼ -61.5% |
| 2014 | -2.55x | $-2.46 Million | $-2.47 Million | $965.00K | ▼ -29.8% |
| 2013 | -1.96x | $-2.42 Million | $-2.50 Million | $1.23 Million | ▼ -129.8% |
| 2012 | -0.85x | $-1.42 Million | $-1.51 Million | $1.66 Million | ▲ +70.0% |
| 2011 | -2.84x | $-1.79 Million | $-1.80 Million | $629.00K | ▼ -280.9% |
| 2010 | -0.75x | $-719.00K | $-735.00K | $963.00K | ▲ +78.8% |
| 2009 | -3.51x | $-2.49 Million | $-2.49 Million | $708.00K | ▲ +33.4% |
| 2008 | -5.28x | $-10.58 Million | $-10.58 Million | $2.00 Million | ▼ -37.2% |
| 2007 | -3.85x | $-21.39 Million | $-21.46 Million | $5.56 Million | ▼ -26.7% |
| 2006 | -3.04x | $-12.57 Million | $-12.59 Million | $4.14 Million | ▼ -13.5% |
| 2005 | -2.67x | $-10.43 Million | $-10.47 Million | $3.90 Million | ▼ -12.5% |
| 2004 | -2.38x | $-14.31 Million | $-14.49 Million | $6.02 Million | ▲ +23.8% |
| 2003 | -3.12x | $-13.24 Million | $-13.33 Million | $4.25 Million | — |